SUBSCRIBE
SUBSCRIBE

PAH Drug Outperforms Expectations

December 18, 2009 | 
1 min read
MedPage Today -- The pulmonary arterial hypertension drug treprostinil (Remodulin) may be more effective than it's given credit for, researchers said.